Work

N-n-alkylnicotinium analogs, a novel class of antagonists at α4β2* Nicotinic acetylcholine receptors: Inhibition of S(-)-nicotine-evoked 86Rb+Efflux from rat thalamic synaptosomes

Year: 2005

Type: article

Source: The AAPS Journal

DOI: 10.1208/aapsj070490

Authors: Lincoln H. Wilkins, Dennis K. Miller, Joshua T. Ayers, Peter A. Crooks, Linda P. Dwoskin

Institutions: University of Kentucky, University of Missouri, AstraZeneca (United States)

Language: English

Topic: Nicotinic Acetylcholine Receptors Study

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute on Drug Abuse

Awards: Developmemt of Novel Treatments for Nicotine Addiction, G2354354576, G4222607367, G4410470734, G477565959, LOBELINE, A POTENTIAL THERAPY FOR METHAMPHETAMINE ABUSE, DEVELOPMENT OF SELECTIVE NICOTINIC RECEPTOR ANTAGONISTS, DEVELOPMENT OF SELECTIVE NICOTINIC RECEPTOR ANTAGONISTS

OpenAlex ID: W2069072591

FWCI: 0.378

Cites: 41

Cited by: 6

Related to: 10